DyAnsys, Inc.

DyAnsys, Inc. is a privately held medical device company headquartered in Los Gatos, California, in the United States. The company operates in the healthcare equipment sector, focusing on the development and commercialization of devices that assess and influence the autonomic nervous system. Its best-known offerings include the ANSiscope, a non-invasive monitor that measures autonomic nervous system activity, and the ANSiStim, a peripheral electrical nerve stimulation device used for pain management and related applications. DyAnsys positions itself at the intersection of neurology, pain management, and autonomic medicine. Its products are used by clinicians and researchers to evaluate autonomic function and to deliver therapeutic stimulation. The company has pursued regulatory clearances in the United States and has sought distribution partnerships in international markets, including Europe and Asia. As a smaller, specialized player in the medical device industry, DyAnsys competes with larger neuromodulation and diagnostic companies. Its strategy has centered on proprietary technology, clinical validation, and niche applications where autonomic assessment can inform treatment decisions. The company remains privately held and does not disclose detailed financial information publicly. Because the available public record on DyAnsys is limited, this dossier relies on the company's known product lines and its Los Gatos headquarters. Specific founding dates, executive names, and financial figures are not included here to avoid speculation.

DyAnsys, Inc. is a medical device company based in Los Gatos, California, United States. The company was established to develop technologies for assessing and modulating the autonomic nervous system, a branch of the nervous system that regulates involuntary body functions such as heart rate, digestion, and blood pressure. DyAnsys's early work centered on the ANSiscope, a non-invasive device designed to measure autonomic nervous system activity. The ANSiscope has been used in clinical and research settings to evaluate autonomic function, which can be relevant in conditions such as diabetes, cardiovascular disease, and chronic pain. The company later developed the ANSiStim, a peripheral electrical nerve stimulation device intended for pain management. The ANSiStim delivers electrical impulses to peripheral nerves and has been studied for applications including post-operative pain and chronic pain syndromes. Over the years, DyAnsys has sought regulatory clearances for its devices in the United States and has pursued international distribution. The company has participated in clinical studies and has presented data at medical conferences. Its products have been marketed to anesthesiologists, pain specialists, neurologists, and researchers. As a privately held company, DyAnsys does not publicly report detailed financial results. Its headquarters in Los Gatos places it within the Silicon Valley region, although it operates in the medical device rather than the software or electronics sector. The company continues to focus on autonomic medicine and neuromodulation, with a product portfolio centered on the ANSiscope and ANSiStim platforms. Specific details such as the exact founding year, founders, and executive leadership are not available in the provided evidence and are therefore omitted.

Specialized medical device company focused on autonomic nervous system assessment and neuromodulation for pain management and clinical diagnostics.

• ANSiscope

  A non-invasive medical device that measures autonomic nervous system activity, used for clinical assessment and research.

• ANSiStim

  A peripheral electrical nerve stimulation device intended for pain management and related therapeutic applications.

1. 1DyAnsys, Inc. (United States) - Wikidatawikidata.org